John B. Sanfilippo & Son, Inc. - Common Stock (JBSS)

Contract manufacturing surges 41% as snack nut demand softens.

John B. Sanfilippo & Son (NASDAQ:JBSS) reported lower first-quarter fiscal 2027 sales and earnings as pricing pressures, a less favorable product mix and higher operating costs weighed on results, while management pointed to stable overall volume trends and growth opportunities in private-label

These three overlooked consumer stocks offer investors dividends, new growth capacity, and catalysts that may take years to fully play out.

John B. Sanfilippo & Son (NASDAQ:JBSS) outlined plans to expand its snack bar manufacturing business while continuing to build on its private-label nut and trail mix operations, during a presentation at the IDEAS Conference. The company, a fourth-generation family-managed processor, marketer and di

Record annual sales and volume growth return despite margin headwinds.

John B. Sanfilippo & Son (NASDAQ:JBSS) reported record fiscal 2026 net sales of $1.2 billion and a 4.6% increase in diluted earnings per share, although fourth-quarter profitability declined as higher costs, recall-related expenses and customer charges pressured margins. For the fiscal fourth q

John B Sanfilippo & Son (NASDAQ:JBSS) reported fourth-quarter financial results on Thursday. The transcript from the company's fourth-quarter earnings call has been provided below. This transcript is brought to

JBSS Q1 2026 Earnings Transcript

These three consumer staples companies are overlooked, but they are quietly building wealth with resilient business models.

John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS), a prominent player in the nut and snack industry, is undergoing a significant strategic transformation, shifting its core identity from a primarily commercial ingredient supplier to a robust, consumer-focused packaged foods enterprise. This calculated pivot, characterized by a heightened emphasis on its private

John B Sanfilippo & Son just reported results for the fourth quarter of 2024.

John B Sanfilippo & Son just reported results for the third quarter of 2024.

Companies Reporting Before The Bell • ATRenew (NYSE:RERE) is estimated to report quarterly earnings at $0.06 per share on revenue of $397.98 million.

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.